A61K 38/217
Ifn-gamma
Official title: {IFN-gamma}
A61K38/217 (Ifn-gamma) appears on 505 US grants and 847 published applications in this corpus.
Search patents in A61K- Granted patents
- 505
- Published applications
- 847
- Assignees
- 394
- Inventors
- 1,391
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 8 | 0 |
| 1991 | 1 | 0 |
| 1992 | 20 | 0 |
| 1993 | 23 | 0 |
| 1994 | 8 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 4 |
| 2002 | 8 | 14 |
| 2003 | 4 | 18 |
| 2004 | 2 | 29 |
| 2005 | 7 | 47 |
| 2006 | 5 | 27 |
| 2007 | 6 | 21 |
| 2008 | 10 | 24 |
| 2009 | 3 | 28 |
| 2010 | 10 | 20 |
| 2011 | 8 | 29 |
| 2012 | 10 | 27 |
| 2013 | 15 | 31 |
| 2014 | 24 | 50 |
| 2015 | 27 | 46 |
| 2016 | 23 | 47 |
| 2017 | 22 | 27 |
| 2018 | 26 | 31 |
| 2019 | 26 | 38 |
| 2020 | 14 | 36 |
| 2021 | 35 | 68 |
| 2022 | 36 | 56 |
| 2023 | 11 | 38 |
| 2024 | 21 | 38 |
| 2025 | 19 | 28 |
| 2026 | 15 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy16 Jun 2026US 12,655,389 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy9 Jun 2026US 12,648,962 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy2 Jun 2026US 12,642,816 B2Iovance Biotherapeutics, Inc.
- Oncolytic virus therapy2 Jun 2026US 12,642,832 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy26 May 2026US 12,636,318 B2Iovance Biotherapeutics, Inc.
- Oncolytic virus therapy1 Oct 2026US 2026/0294987 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272985 A1Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272986 A1Iovance Biotherapeutics, Inc.
- Delivery of protein extracellularly10 Sep 2026US 2026/0263370 A1
- Therapeutics for cancer with antisense and interferon-gamma3 Sep 2026US 2026/0256887 A1Gmp Biotechnology Limited
Most cited
By later US patents
- Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes244US 8,389,282 B2Memorial Sloan Kettering Cancer Center · 2013
- Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody199US 6,455,043 B1IDEC Pharmaceuticals Corporation · 2002
- Treatment of infections with lymphokines110US 4,879,111 ACetus Corporation · 1989
- Method and agents for inhibiting protein aging104US 4,758,583 AThe Rockefeller University · 1988
- Systemic immune activation method using nucleic acid-lipid complexes93US 6,693,086 B1National Jewish Medical and Research Center · 2004